Pharmaron Beijing Co., Ltd. (SHE:300759)

China flag China · Delayed Price · Currency is CNY
27.00
+0.02 (0.07%)
At close: Mar 4, 2026
0.60%
Market Cap 45.37B
Revenue (ttm) 13.54B
Net Income (ttm) 1.51B
Shares Out 1.83B
EPS (ttm) 0.86
PE Ratio 31.54
Forward PE 24.77
Dividend 0.20 (0.74%)
Ex-Dividend Date Jul 4, 2025
Volume 22,076,960
Average Volume 19,747,901
Open 26.90
Previous Close 26.98
Day's Range 26.54 - 27.26
52-Week Range 20.47 - 37.63
Beta 0.97
RSI 29.97
Earnings Date Mar 31, 2026

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotide... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 22,908
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300759
Full Company Profile

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.

Financial Statements

News

There is no news available yet.